Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06523504
PHASE1/PHASE2

Atropine (0.02%, 0.04%) Combined With Defocus DIMS for Moderate and High Myopia Control

Sponsor: Ruihua Wei

View on ClinicalTrials.gov

Summary

To evaluate the effectiveness and safety of DIMS, low concentration atropine eye drops,and atropine combined with DIMS in controlling axial length and refraction in children with moderate to high myopia.

Official title: Efficacy and Safety of Low-concentration Atropine Eye Drops (0.02%, 0.04%) Combined With Defocus Incorporated Multiple Segments (DIMS) for Moderate and High Myopia Control

Key Details

Gender

All

Age Range

6 Years - 12 Years

Study Type

INTERVENTIONAL

Enrollment

410

Start Date

2024-02-01

Completion Date

2026-03-31

Last Updated

2025-09-08

Healthy Volunteers

No

Conditions

Interventions

DEVICE

DIMS

wear DIMS ,and use placebo,once nightly, both eye

DRUG

The 0.02% ATP Group

wear SP, and use 0.02%ATP eye drops, once nightly, both eye

DRUG

The 0.04% ATP Group

wear SP, and use 0.04%ATP eye drops, once nightly, both eye

COMBINATION_PRODUCT

0.02%ATP+DIMS

wear DIMS, and use 0.02%ATP eye drops, once nightly, both eye

COMBINATION_PRODUCT

0.04%ATP+DIMS

wear DIMS, and use 0.04%ATP eye drops, once nightly, both eye

Locations (1)

Tianjin Medical University Eye Hospital

Tianjin, Tianjin Municipality, China